Bank of America’s TCR2 Therapeutics Inc. Common Stock TCRR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-21,166
| Closed | -$31.7K | – | 7076 |
|
|
2023
Q1 | $31.7K | Sell |
21,166
-62,372
| -75% | -$93.6K | ﹤0.01% | 5818 |
|
|
2022
Q4 | $83.4K | Sell |
83,538
-35,129
| -30% | -$35.1K | ﹤0.01% | 5540 |
|
|
2022
Q3 | $213K | Sell |
118,667
-19,277
| -14% | -$34.6K | ﹤0.01% | 5150 |
|
|
2022
Q2 | $400K | Sell |
137,944
-77,982
| -36% | -$226K | ﹤0.01% | 4877 |
|
|
2022
Q1 | $596K | Sell |
215,926
-1,013,353
| -82% | -$2.8M | ﹤0.01% | 5004 |
|
|
2021
Q4 | $5.73M | Buy |
1,229,279
+1,132,206
| +1,166% | +$5.28M | ﹤0.01% | 3020 |
|
|
2021
Q3 | $826K | Buy |
97,073
+87,379
| +901% | +$744K | ﹤0.01% | 4497 |
|
|
2021
Q2 | $159K | Sell |
9,694
-6,811
| -41% | -$112K | ﹤0.01% | 5472 |
|
|
2021
Q1 | $365K | Buy |
16,505
+10,330
| +167% | +$228K | ﹤0.01% | 4992 |
|
|
2020
Q4 | $191K | Buy |
6,175
+304
| +5% | +$9.4K | ﹤0.01% | 4915 |
|
|
2020
Q3 | $119K | Sell |
5,871
-1,382
| -19% | -$28K | ﹤0.01% | 4979 |
|
|
2020
Q2 | $111K | Buy |
7,253
+3,773
| +108% | +$57.7K | ﹤0.01% | 5060 |
|
|
2020
Q1 | $27K | Sell |
3,480
-3,510
| -50% | -$27.2K | ﹤0.01% | 5475 |
|
|
2019
Q4 | $100K | Buy |
6,990
+2,550
| +57% | +$36.5K | ﹤0.01% | 5180 |
|
|
2019
Q3 | $66K | Buy |
4,440
+238
| +6% | +$3.54K | ﹤0.01% | 5390 |
|
|
2019
Q2 | $60K | Buy |
4,202
+1,849
| +79% | +$26.4K | ﹤0.01% | 5454 |
|
|
2019
Q1 | $41K | Buy |
+2,353
| New | +$41K | ﹤0.01% | 5509 |
|